ADENIUM BIOTECH ApS: Financial statements 2015
CVR: 33882785
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
ADENIUM BIOTECH ApS (CVR 33882785) has filed annual accounts for 2015. In 2015, the company reported a net result of DKK -23,602,763 compared with DKK -12,419,168 the year before. Equity in the 2015 report amounted to DKK -23,901,472.
- Profit/Loss
- DKK -23,602,763
- Equity
- DKK -23,901,472
- Total Assets
- DKK 19,197,590
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | - | -23.6M | -23.9M | - |
| 2014 | - | 980K | -12.4M | -299K | - |
| 2013 | - | - | -9.8M | 12.1M | - |
| 2012 | - | -11.5M | -9.6M | 10M | - |
Official annual report
How creditworthy is ADENIUM BIOTECH ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of November 6, 2015, John Howard Rex has joined the board of directors of ADENIUM BIOTECH ApS.
As of November 6, 2015, Joseph Michael Feczko has joined the board of directors of ADENIUM BIOTECH ApS.
ADENIUM BIOTECH ApS has published its annual report for 2014. Gross profit came to DKK 979,682, and the net result was DKK -12,419,168.
As of May 22, 2015, Anker Gunvald Lundemose has left the board of directors of ADENIUM BIOTECH ApS.
As of May 22, 2015, Ejner Bech Jensen has left the board of directors of ADENIUM BIOTECH ApS.
As of May 22, 2015, Paul David Goldenheim is registered as chairman of ADENIUM BIOTECH ApS.
As of May 22, 2015, Khalid Islam has stepped down as chairman of ADENIUM BIOTECH ApS.
As of May 21, 2015, Paul David Goldenheim has left the board of directors of ADENIUM BIOTECH ApS.
As of March 10, 2015, Paul David Goldenheim has joined the board of directors of ADENIUM BIOTECH ApS.
As of March 10, 2015, Paul David Goldenheim is registered as adm. dir. of ADENIUM BIOTECH ApS.
About ADENIUM BIOTECH ApS
ADENIUM BIOTECH ApS was a Danish company of the type Anpartsselskab based in København N, founded in 2011. The company has been dissolved on 4 January 2021. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 1 employee (2020). In 2019, the company reported a gross profit of DKK -2,898,094 and a net result of DKK -3,504,941 compared with DKK -4,602,176 the year before. Equity in the 2019 report amounted to DKK -1,576,302.